'Baseless' Shareholder Action V. Biovail Tossed
A federal judge has dismissed a proposed shareholder class action accusing Biovail Corp. of misleading investors about the antidepressant Aplenzin, calling the lawsuit a "prime exemplar of a legally baseless securities...To view the full article, register now.
Already a subscriber? Click here to view full article